Showing results (91-100 of 119) with videos related to
Sort By:
Pageof 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2005
Italian clinical research in non-small-cell lung cancerC Gridelli, A Rossi, D Galetta, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2006
Raltitrexed plus levofolinic acid and bolus/continuous infusion 5-fluorouracil on a biweekly schedule for elderly patients with advanced colorectal carcinomasV Gebbia, F Verderame, F Ferraù, et al.International Journal of Oncology|May 5, 2011
Neo-adjuvant organ-preserving chemotherapy in the management of locally advanced oral cavity and oropharynx cancerG Mantovani, V Gebbia, E Proto, et al.Bollettino Dell'Istituto Sieroterapico Milanese|January 1, 1990
Soluble interleukin-2 receptor in vitro production by mononuclear cells from Hodgkin patientsC Caruso, M A Modica, G Candore, et al.La Clinica Terapeutica|July 20, 2022
Management of Patients with Gastric or Gastroesophageal Junction Cancer: From Theory to Integrated Clinical Path- ways Implementation in the Real WorldR Guggino, N Borsellino, M Spada, et al.Melanoma Research|February 6, 2003
Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen, or vindesine plus tamoxifen: a prospective randomized studyG Cocconi, R Passalacqua, S Foladore, et al.International Journal of Oncology|May 5, 2011
Neo-adjuvant (primary) organ-preserving chemotherapy in the management of locally advanced laryngeal carcinomaG Mantovani, V Gebbia, E Proto, et al.International Journal of Oncology|May 18, 2011
Subcutaneous recombinant-human-erythropoietin prevents chemotherapy-related anemia in patients with advanced cancerV Gebbia, N Gebbia, A Testa, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2005
FOLFIRI regimen in advanced colorectal cancer: the experience of the Gruppo Oncologico dell'Italia Meridionale (GOIM)E Maiello, V Gebbia, F Giuliani, et al.International Journal of Oncology|May 14, 2011
Elf regimen in advanced gastrointestinal malignancies - an analysis of its clinical effectiveness and toxicityV Gebbia, C Sciume, G Cannata, et al.Pageof 12